- Home
- TPST vs NMTC Comparison
TPST vs NMTC Comparison
Compare TPST & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- NMTC
- Stock Information
- Founded
- TPST 2011
- NMTC 2009
- Country
- TPST United States
- NMTC United States
- Employees
- TPST N/A
- NMTC N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- TPST Health Care
- NMTC Health Care
- Exchange
- TPST Nasdaq
- NMTC Nasdaq
- Market Cap
- TPST 33.0M
- NMTC 33.8M
- IPO Year
- TPST N/A
- NMTC N/A
- Fundamental
- Price
- TPST $6.95
- NMTC $0.71
- Analyst Decision
- TPST Hold
- NMTC Strong Buy
- Analyst Count
- TPST 3
- NMTC 1
- Target Price
- TPST $30.00
- NMTC $1.45
- AVG Volume (30 Days)
- TPST 90.3K
- NMTC 176.5K
- Earning Date
- TPST 08-07-2025
- NMTC 08-13-2025
- Dividend Yield
- TPST N/A
- NMTC N/A
- EPS Growth
- TPST N/A
- NMTC N/A
- EPS
- TPST N/A
- NMTC N/A
- Revenue
- TPST N/A
- NMTC $5,758,777.00
- Revenue This Year
- TPST N/A
- NMTC $157.28
- Revenue Next Year
- TPST N/A
- NMTC $41.79
- P/E Ratio
- TPST N/A
- NMTC N/A
- Revenue Growth
- TPST N/A
- NMTC 54.53
- 52 Week Low
- TPST $5.35
- NMTC $0.40
- 52 Week High
- TPST $30.03
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- TPST 46.97
- NMTC 65.31
- Support Level
- TPST $7.06
- NMTC $0.72
- Resistance Level
- TPST $7.64
- NMTC $0.77
- Average True Range (ATR)
- TPST 0.27
- NMTC 0.05
- MACD
- TPST 0.02
- NMTC 0.01
- Stochastic Oscillator
- TPST 31.91
- NMTC 82.02
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.